MIGLUSTAT | MIGLUSTAT | ATC A16AX06
METABOLISM TYPE 1 GAUCHER DISEASE GLUCOSYLCERAMIDE SYNTHASE INHIBITOR SYNTHESIS OF MOST GLYCOSPHINGOLIPIDS TREATMENT OF NIEMANN-PICK TYPE C DISEASE (DRUG FOR RARE DISEASE IN EUROPE) | ORAL | Tmax 2.25 HOUR F 97 PERCENT VD 94 LITER PPB 0 PERCENT HT 6.5 HOUR SOLUBILITY HIGHLY SOLUBLE IN WATER (> 1000 MILLIGRAM / MILLILITER) | GLUCOSYLCERAMIDE SYNTHASE PDB 2V3D (ACID-BETA-GLUCOSIDASE WITH N-BUTYL-DEOXYNOJIRIMYCIN) LIGAND CODE = NBV (link to the list of PDB complexes) Download experimental 3D coordinates of NBV with added hydrogens | CERAMIDE GLUCOSYLTRANSFERASE INHIBITOR CHEMBL2063 CERAMIDE GLUCOSYLTRANSFERASE Q16739 CERAMIDE GLUCOSYLTRANSFERASE HOMO SAPIENS ENZYME TRANSFERASE | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |